3D Tumor Spheroid Invasion Assay

Reagents and chemicals

• Tumor cells are cultured as multicellular spheroids before embedding in a 3D matrix^[1][2][3][4].

• Reported invasion matrices include collagen I, basement membrane extract or Matrigel-type matrices, human myoma-derived matrix with fibrin, collagen-alginate hydrogels, and engineered peptide-functionalized hydrogels^[2][3][5][6].

• Culture medium supports spheroid formation, matrix embedding, and longitudinal imaging during invasion^[1][3][4].

Antibodies, probes, dyes, or kits

• Fluorescent cell labeling can be used for live-cell tracking or endpoint imaging, and immunostaining or molecular assays may be used after invasion to examine invasive-cell phenotypes^[3][5][6].

• Image-analysis tools such as Fiji/ImageJ, ilastik, imaging cytometry, or semi-automated analysis pipelines have been used to quantify spheroid invasion from microscopy images^[1][2][3][4].

Equipment and instruments

• Ultra-low-attachment round-bottom or U-shaped plates support formation of uniform spheroids for invasion assays^[1][2].

• Standard or automated microscopy platforms are used for endpoint, daily, longitudinal, or time-lapse imaging of spheroid invasion^[1][2][3][4].

• A humidified cell-culture incubator maintains spheroids during matrix polymerization and invasion culture^[1][3][4].

Preparation Steps

• Prepare tumor-cell suspensions and seed cells into a non-adherent spheroid-forming format so that compact spheroids form before matrix embedding^[1][2][4].

• Select the matrix according to the biological question, because matrix type, composition, concentration, stiffness, and architecture can alter invasion behavior^[4][5][6].

Operation Steps

• Generate spheroids, confirm spheroid compactness and comparable starting size, and embed each spheroid in the selected matrix before imaging^[1][2][3][4].

• Allow the matrix system to support three-dimensional invasion, then image the same spheroids at defined time points or by time-lapse microscopy; published workflows include daily imaging, longitudinal imaging, and time-resolved fluorescence imaging^[2][3][4].

• When comparing treatments or genetic conditions, keep spheroid size, matrix formulation, imaging schedule, and analysis method consistent across experimental groups^[1][3][4].

Data Acquisition and Analysis

• Quantify invasion by measuring the expansion of the invasive area beyond the spheroid core, invasion distance, cell dispersion, or single-cell movement metrics when time-lapse imaging is available^[1][3][4].

• Normalize or compare invasion measurements against baseline spheroid size when appropriate, because starting spheroid size and matrix position can influence measured invasion patterns^[1][4].

• Include non-invasive or weakly invasive cells, untreated controls, vehicle controls, and replicate spheroids for each condition when comparing invasion phenotypes or drug responses^[1][4][6].

Problem: Invasion differs strongly between replicate spheroids.

• Possible Cause: Spheroid size, compactness, or position in the matrix differs between wells.
• Literature-supported Solution: Use a standardized spheroid-forming method, confirm comparable starting spheroids, and exclude or separately analyze spheroids positioned in ways that bias movement paths^[1][4].

Problem: Cells show weak or absent invasion.

• Possible Cause: The matrix formulation does not support invasion for that cell type.
• Literature-supported Solution: Optimize matrix content and concentration before larger experiments, because matrix composition and physical properties can change invasion behavior^[4][5][6].

Problem: Fluorescent or immunostaining signal is uneven inside spheroids.

• Possible Cause: Antibodies and dyes may penetrate spheroids inefficiently.
• Literature-supported Solution: Use validated live-labeling, optimized fixation/staining, or image-analysis workflows designed for spheroid invasion imaging^[3].